Skip to main content
search
Tag

AMR

HighlightsHighlights Archive

NHS failing to meet vital AMR targets

The NHS is set to miss two critical targets in tackling AMR – as outlined in a five-year AMR action plan unveiled by the government in 2019. The targets expected to be missed are: reducing the number of three gram-negative bacteria from bloodstream infections in healthcare settings by 25% by March this year, and 50% by 2024. Current figures show…
Ben Kemp
April 22, 2022
HighlightsHighlights Archive

NICE undertakes world-first evaluation of antimicrobial drugs to tackle AMR

In a historic move, cefiderocol and ceftazidime–avibactam will become the first antimicrobial drugs authorised by NICE for use in the UK’s new subscription-style payment model. This forms part of a larger scheme with NHSE/I and DHSC to provide a greater incentive to research and develop much-needed antimicrobial drugs for the future. The dearth of new antimicrobials being developed and the…
Ben Kemp
April 14, 2022
Close Menu